NBCD A/S: Financial statements 2018
CVR: 30582462
NBCD A/S (CVR 30582462) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 26,749,241 and a net result of DKK 16,252,006 compared with DKK 20,785,529 the year before. That is an increase of 8.8% compared with the year before. Equity amounted to DKK 17,752,594. The solvency ratio was 31.5%. The company had 25 employees in the financial year.
- Gross Profit
- 26,749,241 kr.
- Profit/Loss
- 16,252,006 kr.
- Equity
- 17,752,594 kr.
- Total Assets
- 56,358,889 kr.
- Employees
- 25
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 26.7 mio. | 16.3 mio. | 17.8 mio. | 25 |
| 2017 | - | 24.6 mio. | 20.8 mio. | 21.5 mio. | - |
| 2016 | - | 12.7 mio. | 14 mio. | 9.7 mio. | - |
| 2015 | - | -6.1 mio. | 37.9 mio. | 44.2 mio. | - |
| 2014 | - | 1.6 mio. | 29.2 mio. | 6.3 mio. | - |
Keep an eye on NBCD A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
As of September 4, 2018, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of NBCD A/S.
As of September 4, 2018, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of NBCD A/S.
NBCD A/S has published its annual report for 2017. Gross profit came to DKK 24,576,095, and the net result was DKK 20,785,529.
About NBCD A/S
NBCD A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S and NORDIC BIOSCIENCE PROJECT 2 A/S. The management consists of Jeppe Ragnar Andersen and Mark Høgh Gandrup. The company is owned by Sanos Holding A/S. The company has 24 employees. In 2025, the company reported a gross profit of DKK 31,583,144 and a net result of DKK 9,222,892 compared with DKK 52,621,101 the year before. Equity amounted to DKK 136,144,994.
